For investors seeking momentum, WisdomTree US Quality Dividend Growth ETF (DGRW - Free Report) is probably on radar now. The fund just hit a 52-week high, and is up about 24.6% from its 52-week low price of $27.45 per share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
DGRW in Focus
This ETF looks to follow the investment results of dividend-paying large-cap companies with growth characteristics in the U.S. equity market. The fund has a large cap focus with key holdings in the Information Technology, Industrials, Health Care, Consumer Discretionary and Consumer Staples segments. DGRW charges investors 28 basis points a year in fees and has top holdings in Johnson & Johnson, Apple and Microsoft (see: all large-cap ETFs here).
Why the Move?
Markets may be hitting highs sporadically, but uncertainty prevails. President Trump’s controversial plans and policies like immigration curb, travel ban, border tax, and termination of trade agreements have flared up concerns over trade, economic growth and political stability. In such a scenario, investors will definitely want to bet on quality dividend stocks like what we see in this ETF portfolio.
More Gains Ahead?
Currently, DGRW has a Zacks ETF Rank #2 (Buy) with a Medium risk outlook. The fund also has a positive weighted alpha of 19.00. A positive weighted alpha hints at more gains.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors seeking momentum, WisdomTree US Quality Dividend Growth ETF (DGRW - Free Report) is probably on radar now. The fund just hit a 52-week high, and is up about 24.6% from its 52-week low price of $27.45 per share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
DGRW in Focus
This ETF looks to follow the investment results of dividend-paying large-cap companies with growth characteristics in the U.S. equity market. The fund has a large cap focus with key holdings in the Information Technology, Industrials, Health Care, Consumer Discretionary and Consumer Staples segments. DGRW charges investors 28 basis points a year in fees and has top holdings in Johnson & Johnson, Apple and Microsoft (see: all large-cap ETFs here).
Why the Move?
Markets may be hitting highs sporadically, but uncertainty prevails. President Trump’s controversial plans and policies like immigration curb, travel ban, border tax, and termination of trade agreements have flared up concerns over trade, economic growth and political stability. In such a scenario, investors will definitely want to bet on quality dividend stocks like what we see in this ETF portfolio.
More Gains Ahead?
Currently, DGRW has a Zacks ETF Rank #2 (Buy) with a Medium risk outlook. The fund also has a positive weighted alpha of 19.00. A positive weighted alpha hints at more gains.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on DGRW - FREE